Table 2.
Conditions | Reaction time (ms) | Number of misses | Number of false alarms |
---|---|---|---|
Baseline placebo (BP) | 603 ± 138 | 4.7 ± 4.1 | 1.8 ± 1.5 |
Baseline caffeine (BC) | 609 ± 126 | 4.9 ± 3.8 | 1.7 ± 1.6 |
(BC-BP) | 6 ± 59 | 0.1 ± 1.6 | − 0.1 ± 2.0 |
Placebo (DP) | 599 ± 130 | 5.4 ± 5.2 | 2.1 ± 1.4 |
Caffeine (DC) | 598 ± 145 | 2.7 ± 1.9+⁎§ | 1.5 ± 1.2 |
(DC–DP) | 1 ± 81 | − 2.7 ± 3.0 | − 0.6 ± 1.5 |
+Significant interaction effect of dosing (baseline or post-dose scan) × drug (placebo or caffeine) in a 2-way repeated-measures ANOVA, p < 0.05.
⁎Significantly different with respect to baseline caffeine (two-tailed post-hoc paired t-test p < 0.05).
§Significantly different with respect to placebo (two-tailed post-hoc paired t-test p < 0.05).